Rossler, A., Pfaus, J., Kia, H., Bernabe, J., Alexandre, L., & Giuliano, F
Key risks include lean muscle mass loss, heart rate elevation, pancreatitis, gallbladder disease, hypoglycaemia, and acute kidney injury from dehydration
Both leverage the same active compoundsemaglutideto reduce appetite and improve metabolic control, yet they differ significantly in formulation, cost, and accessibility
Digestive bitters (bitter herbs) prior to meals is advised
Reduce la secrecin de glucagn: el glucagn es otra hormona producida por el pncreas que tiene un efecto opuesto al de la insulina, aumentando los niveles de azcar en la sangre, por ejemplo, cuando el organismo est en ayunas
This is the same pathway activated by semaglutide and is the foundation of modern medical weight loss